137 related articles for article (PubMed ID: 22993327)
1. NAC1, a BTB/POZ protein overexpressed in uterine sarcomas.
Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Yamada T; Miyazaki K
Anticancer Res; 2012 Sep; 32(9):3841-5. PubMed ID: 22993327
[TBL] [Abstract][Full Text] [Related]
2. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
4. Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen.
Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Clin Cancer Res; 2009 Feb; 15(3):804-11. PubMed ID: 19188150
[TBL] [Abstract][Full Text] [Related]
5. Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma.
Nishi T; Maruyama R; Urano T; Nakayama N; Kawabata Y; Yano S; Yoshida M; Nakayama K; Miyazaki K; Takenaga K; Tanaka T; Tajima Y
Pathol Int; 2012 Dec; 62(12):802-10. PubMed ID: 23252869
[TBL] [Abstract][Full Text] [Related]
6. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
7. ERBB-2 gene overexpression and amplification in uterine sarcomas.
Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
10. NAC1, a POZ/BTB protein that functions as a corepressor.
Korutla L; Wang P; Jackson TG; Mackler SA
Neurochem Int; 2009; 54(3-4):245-52. PubMed ID: 19121354
[TBL] [Abstract][Full Text] [Related]
11. Identification of suitable reference genes for gene expression measurement in uterine sarcoma and carcinosarcoma tumors.
Kowalewska M; Danska-Bidzinska A; Bakula-Zalewska E; Bidzinski M
Clin Biochem; 2012 Mar; 45(4-5):368-71. PubMed ID: 22266404
[TBL] [Abstract][Full Text] [Related]
12. Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.
Rushing RS; Shajahan S; Chendil D; Wilder JL; Pulliam J; Lee EY; Ueland FR; van Nagell JR; Ahmed MM; Lele SM
Gynecol Oncol; 2003 Oct; 91(1):9-14. PubMed ID: 14529657
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas.
Coosemans A; Nik SA; Caluwaerts S; Lambin S; Verbist G; Van Bree R; Schelfhout V; de Jonge E; Dalle I; Jacomen G; Cassiman JJ; Moerman P; Vergote I; Amant F
Eur J Cancer; 2007 Jul; 43(10):1630-7. PubMed ID: 17531467
[TBL] [Abstract][Full Text] [Related]
15. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
Parker WH; Fu YS; Berek JS
Obstet Gynecol; 1994 Mar; 83(3):414-8. PubMed ID: 8127535
[TBL] [Abstract][Full Text] [Related]
16. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
17. PDGFR-alpha as a potential therapeutic target in uterine sarcomas.
Adams SF; Hickson JA; Hutto JY; Montag AG; Lengyel E; Yamada SD
Gynecol Oncol; 2007 Mar; 104(3):524-8. PubMed ID: 17049587
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902
[TBL] [Abstract][Full Text] [Related]
19. Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters.
Kitaoka Y; Kitawaki J; Koshiba H; Inoue S; Ishihara H; Teramoto M; Honjo H
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):183-9. PubMed ID: 15084350
[TBL] [Abstract][Full Text] [Related]
20. C-kit protein expression in uterine and ovarian mesenchymal tumours.
Erdogan G; Bassorgun CI; Pestereli HE; Simsek T; Karaveli S
APMIS; 2007 Mar; 115(3):204-9. PubMed ID: 17367465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]